Free shipping on all orders over $ 500

GLP Receptor Glucagon-like peptide Receptor

Cat.No.  Name Information
M10249 Teduglutide Teduglutide is a glucagon-like peptide-2 (GLP-2) analogue used for the treatment of short-bowel syndrome.
M45167 Liraglutide Liraglutide is a glucagon-like peptide-1 (GLP-1) receptor agonist that may be used in studies related to type 2 diabetes.
M31369 Beinaglutide TFA Beinaglutide TFA is a recombinant human GLP-1 (rhGLP-1) peptide and a GLP-1R agonist that can be used in studies related to obesity and non-alcoholic steatohepatitis (NASH).
M31345 Glepaglutide Glepaglutide is a novel, long-acting glucagon-like peptide-2 (GLP-2) analog and a potent GLP-2R agonist. Glepaglutide is used in studies related to inflammatory bowel disease (IBD) and Crohn's disease.
M31031 Apraglutide TFA Apraglutide TFA (FE 203799 TFA), a synthetic 33-amino-acid peptide and a long-acting GLP-2 analogue, enhances adaptation and linear intestinal growth in a neonatal piglet model of short bowel syndrome with total resection of the ileum.
M28126 Apraglutide Apraglutide (FE 203799) is a potentially best-in-class, potent, synthetic 33-amino acid peptide and long-acting GLP-2 analog that can be used in studies related to short bowel syndrome (SBS).
M27757 GLP-1(7-36), amide TFA GLP-1(7-36), amide TFA is a physiological incretin hormone that stimulates insulin secretion.
M25593 PF-07081532 PF-07081532 is a next-generation orally active GLP-1 receptor agonist.
M25390 Dapiglutide Dapiglutide (ZP7570) is a long-acting glucagon-like peptide-1 receptor 1R (GLP-1R)/Glucagon-like peptide-2 receptor (GLP-2R) dual agonist.
M21658 Taspoglutide Taspoglutide is a long-acting glucagon-like peptide 1 (GLP-1) receptor agonist developed for treatment of type 2 diabetes, with an EC50 value of 0.06 nM.
M21288 LY3502970 LY3502970 (GLP-1 receptor agonist 1) is an orally active glucagon-like peptide (GLP-1) receptor partial agonist for studies related to type 2 diabetes and obesity.
M13970 Lixisenatide acetate Lixisenatide acetate is a glucagon-like peptide-1 (GLP-1) receptor agonist that can be used in the treatment of type 2 diabetes mellitus (T2DM).
M13968 GLP-1(7-36), amide acetate GLP-1(7-36), amide acetate is a major intestinal hormone that stimulates glucose-induced insulin secretion from β cells.
M13967 GLP-1(7-37) acetate GLP-1(7-37) acetate is an intestinal insulinotropic hormone that augments glucose induced insulin secretion.
M11319 GLP-1(7-36), amide TFA TFA is a major intestinal hormone that stimulates insulin secretion by pancreatic beta cells in response to glucose.
M11207 GLP-1(7-37) Glp-1 (7-37) is an intestinal insulin hormone that enhances glucose-induced insulin secretion.
M10802 Exenatide Acetate (Exendin-4) Exenatide Acetate (Exendin-4) is a first-in-class glucagon-like peptide 1 (GLP-1) receptor agonist consisting of 39 amino acids.
M10311 Danuglipron (PF-06882961) Danuglipron (PF-06882961) is a potent, orally bioavailable agonist of the glucagon-like peptide-1 receptor (GLP-1R) agonist.
M10089 Avexitide (Exendin 9-39) Avexitide (Exendin 9-39) is a specific and competitive GLP-1 receptor antagonist.
M10044 Albiglutide Albiglutide is a recombinant fusion protein consisting of two copies of a 30-amino-acid sequence of modified human GLP-1 (fragment 7-36), modified with a glycine substituted for the naturally occurring alanine at position 8 in order to augment resistance to DPP-4.

Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2024 AbMole BioScience. All Rights Reserved.